Adastra Announces Fulfillment of Distillate & Vape Cart Purchase Orders
LANGLEY, BC / ACCESSWIRE / August 12, 2020 – Adastra Labs Inc. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the fulfillment of its purchase order for bulk distillate and an order for 30,000 vaporizing cartridges from CannMart Inc. (“CannMart”) a majority owned subsidiary of
Adastra Labs Inc. Announces Submission of Sales Licence Amendment
LANGLEY, BC / ACCESSWIRE / August 5, 2020 – Adastra Labs Inc. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the submission of its federal sales licence amendment to Health Canada. “The submission of sales licence amendment is significant as it represents the successful
Adastra Announces Phyto Extractions Vape Cartridge Order
LANGLEY, BC / ACCESSWIRE / July 15, 2020 – Adastra Labs Inc. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the receipt of a purchase order for 30,000 vaporizing cartridges from CannMart Inc. (“CannMart”) a majority owned subsidiary of Namaste Technologies Inc. (“Namaste”) (TSX-V: N)
Adastra Closes $3.49 Million Oversubscribed Private Placement
LANGLEY, BC/ ACCESSWIRE / July 14, 2020 / Adastra Labs Inc. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”, “XTRX”, or the “Company”) is pleased to announce the closing of its previously announced non-brokered private placement offering (see press releases dated June 18, 2020 and June 25, 2020) issuing 11,648,001 units (the “Units”) for aggregate gross proceeds of
Adastra Increases Private Placement Financing
LANGLEY, BC/ June 25, 2020 / Adastra Labs Inc. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”, “XTRX”, or the “Company”) a Health Canada Licensed cannabis processing and analytical testing services company announces that it plans to increase its previously announced private placement offering (see press release dated June 18, 2020), of units (the “Units“) at a price of
Adastra Announces Private Placement Financing
June 18, 2020 – Adastra Labs Inc. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”, “XTRX”, or the “Company”) a Health Canada Licensed cannabis processing and analytical testing company announced today that it will be conducting a non-brokered private placement of units (the “Units“) at a price of $0.30 per Unit for gross proceeds of up to $1,000,000
Contact Us
Have a question? Want more information? Looking for a partner to deliver the exceptional service you need for your future business? If you're passionate about cannabis, we'd love to hear from you.
F: 844-874-9893
E: info@adastralabs.ca
5451 275th Street,
Langley, BC, Canada, V4W 3X8